Cancer stem cell inhibitor
US-11400076-B2 · Aug 2, 2022 · US
Pola Pharma Inc holds 32 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 32 |
| Recent patents | 0 |
| First publication | Feb 10, 2015 |
| Latest publication | Aug 2, 2022 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-11400076-B2 · Aug 2, 2022 · US
US-2020268716-A1 · Aug 27, 2020 · US
US-2019111026-A1 · Apr 18, 2019 · US
US-10130610-B2 · Nov 20, 2018 · US
US-9968591-B2 · May 15, 2018 · US
Representative or frequently cited publications from precomputed assignee stats.
US-11400076-B2 · Aug 2, 2022 · US
US-2020268716-A1 · Aug 27, 2020 · US
US-2019111026-A1 · Apr 18, 2019 · US
US-10130610-B2 · Nov 20, 2018 · US
US-9968591-B2 · May 15, 2018 · US
Most common classification codes in this portfolio.
| CPC | Patents |
|---|---|
| A61P31/10 | 27 |
| A61K31/4178 | 25 |
| C07D409/06 | 16 |
| A61K9/0014 | 10 |
| C07B2200/13 | 10 |
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 32 |
| Chemistry & Metallurgy | 18 |
| Physics | 5 |
| Operations & Transport | 2 |
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.